Researchers have discovered a factor that could support the early detection of neurodegenerative diseases such as Alzheimer's or Parkinson's. This cytokine is induced by cellular stress reactions after disturbances of the mitochondria, the "cell's power plants," as neuropathologists write in the journal Cell Reports.
The normal functioning of human cells is based on the coordinated interaction of different cellular organelles. In many cases, an impaired communication between these organelles will lead to the activation of a stress response to ensure the survival of affected cells. A research group was able to demonstrate this in detail for brain neurons.
The neuropathologists were able to show that impairments on the level of mitochondria also affect neighboring organelles, such as the so-called endoplasmic reticulum. A consecutively activated stress reaction leads to the release of fibroblast growth factor-21 (FGF21) by nerve cells with disturbed mitochondria. They show that neuron-specific, inducible in vivo ablation of the mitochondrial fission protein Drp1 causes ER stress, resulting in activation of the integrated stress response to culminate in neuronal expression of the cytokine Fgf21.
The researchers further observed that the same substance is also induced in various models of neurodegenerative disorders, where it can be detected prior to neuronal cell death.
As chronic cell stress is an important factor in the development of neurodegenerative diseases, FGF21 could potentially be suitable as a biomarker for the pre-symptomatic detection of diseases such as Alzheimer's or Parkinson's. However, as FGF21 can also be produced by other tissues and organs, such as adipose tissue and liver, further rigorous testing will be required in this regard. The availability of a robust biomarker would represent an important advance in the development of novel approaches targeting chronic cell stress to provide neuroprotection.
https://www.cell.com/cell-reports/fulltext/S2211-1247(18)31113-6?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124718311136%3Fshowall%3Dtrue
Early marker for dementias?
- 1,461 views
- Added
Edited
Latest News
Dopamine-based mechanism for transient forgetting
Synaptic size determines their signaling strength
Convalescent plasma treatment for immunodeficient COVID-19 patient
Reading system relies on general-purpose mechanisms
Metabolic remodeling by vegan diet in young children
Other Top Stories
Brief beneficial effect of one amino acid in short term lowering glucose levels
Health risk prediction from metabolome in obese people
New twist in diabetes - fat has a role to play!
Low copper levels linked to fatter fat cells
Hyperglycemia from chronic stress may cause spatial memory impairment!
Protocols
Dual-Angle Protocol for Doppler Optical Coherence Tomography to Improve Retinal Blood Flow Measur…
Detection of protein SUMOylation in vivo
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induce…
Determination of SUMOylation sites
miR-Selection 3'UTR Target Selection Kit
Publications
Postinfectious Epigenetic Immune Modifications – A Double-Edged Sword
Alpha 5 subunit-containing GABAA receptors in temporal lobe epilepsy with normal MRI
Sex differences in immune responses
Convalescent plasma-mediated resolution of COVID- 19 in a patient with humoral immunodeficiency
A general-purpose mechanism of visual feature association in visual word identification and beyond
Presentations
Homeostasis
PLANT MITOCHONDRIAL BIOLOGY
Photosynthesis
Endocrine Disorders
THE PITUITARY GLAND
Posters
ACMT 2020 Annual Scientific Meeting Abstracts - New York, NY
Abstracts from the 2020 Annual Scientific Meeting of the British and Irish Hypertension Society (…
ACNP 58th Annual Meeting: Poster Session III
ACNP 58th Annual Meeting: Poster Session II
ACNP 58th Annual Meeting: Poster Session I